Platelet-rich Plasma (PRP) Treatment for Medial Retinaculum Tear Post Medial Patellar Dislocation

To check the influence of injected platelet-rich plasma (PRP) on the healing of medial retinaculum and the redaction in recurrent dislocation of the patella.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Patella-Dislocation Joint Diseases Joint Dislocations Knee Injuries Leg Injuries Musculoskeletal Diseases Patellar Dislocation Wounds and Injuries

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2 / Phase 3

Primary location

Meir medical center

Kfar Saba, Israel

About this study

Autologous platelet-rich matrices may aid in the healing of ligaments & tendons by promoting and accelerating tissue healing because of the release of growth factors including transforming growth factor (TGF)-beta1 and platelet-derived growth factor (PDGF) from platelet alpha-granules.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

age 18-40 years old
first time patella dislocation

Exclusion criteria

pregnancy
mental or physical disabilities

Treatment and study plan

Plasma Rich in Growth Factors (PRGF)

Biological

US guided IM injection 3-6mg

Other names: platelet-derived preparation rich in growth factors

Placebo

Drug

injection of 6 cc of saline into injured area

Other names: saline 0.9% NaCl

Primary outcomes

redaction in healing time and recurrence

Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Meir Medical Center

Other

Registry information

Official study title

PRP Treatment for Medial Retinaculum Tear - Randomized-Double-Blind-Placebo Control Trail

Important dates

Study start: 2008
Primary completion: 2009
Study completion: 2009
First posted: Aug 29, 2008
Registry last updated: Jul 12, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed